Fusion Antibodies plc (LON:FAB) Insider Adrian Kinkaid Buys 83,728 Shares

Fusion Antibodies plc (LON:FAB) insider Adrian Kinkaid purchased 83,728 shares of the firm’s stock in a transaction on Wednesday, October 16th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £3,349.12 ($4,373.36).

Adrian Kinkaid also recently made the following trade(s):

• On Wednesday, September 4th, Adrian Kinkaid acquired 120,000 shares of Fusion Antibodies stock. The stock was purchased at an average cost of GBX 3 ($0.04) per share, with a total value of £3,600 ($4,700.97).

Fusion Antibodies Trading Up 18.1 %

Fusion Antibodies stock opened at GBX 4.90 ($0.06) on Thursday. The company has a 50 day moving average price of GBX 3.61 and a 200 day moving average price of GBX 3.51. Fusion Antibodies plc has a 52 week low of GBX 2.80 ($0.04) and a 52 week high of GBX 9.50 ($0.12). The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87. The firm has a market capitalization of £4.67 million, a price-to-earnings ratio of -120.00 and a beta of 0.49.

Fusion Antibodies Company Profile

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.